Total Results: 12366
Gov. Jerry Brown signed the measure, which takes effect next year and will require drug companies to publicly justify big price increases.
A selection of opinions on health care from around the country.
Media outlets report on news from California, Florida, Kansas, Maryland, Massachusetts, Wisconsin and Pennsylvania.
Scientists are working to understand how the body’s clock affects disease, heart attacks, obesity and more health problems. In other public health news: breast cancer, health care marketing, flu shots, heart disease, and more.
For pharmaceutical companies, California is seen as a bellwether state that often sets the pace and tone for other legislative efforts around the country.
Administrators and physicians say they’re impressed with how the programs have engaged physicians to produce lower costs and better outcomes.
“If he wants to work together to improve the existing health care system, we Democrats are open to his suggestions,” Senate Minority Leader Chuck Schumer (D-N.Y.) says. “A good place to start might be the Alexander-Murray negotiations that would stabilize the system and lower costs.”
The White House plans to issue executive orders to promote selling insurance across state lines and “association health plans,” which would allow small employers to band together to offer coverage that wouldn’t be subject to the full range of ACA requirements. But some insurers fear that associations would peel off healthier and younger individuals and leave traditional insurance plans to cover sicker and older customers.
Eight teaching centers in California aim to train and retain doctors in medically underserved areas such as California’s Central Valley. They are among 57 such institutions across the country that may soon receive a boost in funding from Congress.
En el Valle Central de California, no hay una escuela de medicina, y los nuevos médicos a menudo evitan el área en favor de los centros urbanos más ricos, donde pueden ganar más dinero.
Media outlets report on news from California, Illinois, Washington and Kansas.
State and city officials are working to sort out how to deal with a $2.6 billion reduction in federal funds for all state hospitals. Also, Politico examines the impact of the growing number of closures of rural hospitals, and voters in Oregon are likely to be asked to approve a new tax on health providers.
A federal appeals court reverses a sales ban on Sanofi and Regeneron’s pricey cholesterol medicine Praluent. In other pharmaceutical industry news, the FDA considers looser safety protocols on compounded drugs.
More than 55 million women have access to birth control without copayments because of the contraceptive coverage mandate in the Affordable Care Act.
“If it gets signed by this governor, it’s going to send shock waves throughout the country,” one legislator says. Pharma has spent $16.8 million lobbying against this bill and other drug laws in California.
“It looks more like a part of the developing world than it looks like the United States of America,” Robin Koval, president of the Truth Initiative which released the report, says of the 12 states. In other public health news: blood pressure, a mysterious illness, domestic violence and rare genetic diseases.
Las Vegas only has one of these “gold standard” centers, but it’s not the only big city to have so few. Experts say that in situations such as Sunday’s mass shooting what matters most is not the number of high-level centers, but the degree of coordination across a region’s medical network.
Politico reporters describe what went into tracking former HHS Secretary Tom Price’s use of chartered jets. In other news, House Democrats want details on White House adviser Kellyanne Conway’s trips.
Teva had lobbied the Food and Drug Administration to reject Mylan’s generic version of its Copaxone multiple sclerosis medication. In other drug industry news: an experimental drug is found to work on a mutant gene; advocates await Calif. Gov. Jerry Brown’s decision on a drug pricing bill; and Cleveland Clinic’s CEO wants supporters of a drug pricing ballot measure in Ohio to stop using his image.
But Republicans are not actually planning to impose any of those cuts which are limited to nonbinding promises. Meanwhile, angry Republican donors are sitting on their wallets until lawmakers actually accomplish something.